Should You Buy DarioHealth Corp (DRIO) Stock on Thursday?

The market has been high on DarioHealth Corp (DRIO) stock recently. DRIO gets a Bullish score from InvestorsObserver Stock Sentiment Indicator.

DarioHealth Corp has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on DRIO!

See Full DRIO Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With DRIO Stock Today?

DarioHealth Corp (DRIO) stock has risen 2.96% while the S&P 500 is down -1.1% as of 2:26 PM on Thursday, Sep 21. DRIO has gained $0.09 from the previous closing price of $3.04 on volume of 101,116 shares. Over the past year the S&P 500 is up 12.91% while DRIO is down -19.12%. DRIO lost -$2.31 per share in the over the last 12 months. To screen for more stocks like DarioHealth Corp click here.

More About DarioHealth Corp

DarioHealth Corp. is a leading global digital therapeutics company revolutionizing how people with chronic conditions manage their health. DarioHealth offers one of the most comprehensive digital therapeutics solutions on the market - covering multiple chronic conditions including diabetes, hypertension, weight management, musculoskeletal and behavioral health within one integrated technology platform. Dario's next-generation, AI-powered, digital therapeutic platform supports more than just an individual's disease. Dario provides adaptive, personalized experiences that drive behavior change through evidence-based interventions, intuitive, clinically proven digital tools, high-quality software, and coaching to help individuals improve health and sustain meaningful outcomes. Click Here to get the full Stock Report for DarioHealth Corp stock.